Showing results (181-190 of 228) with videos related to
Sort By:
Pageof 23
The Oncologist|February 12, 2020
FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host DiseaseDonna Przepiorka, Lola Luo, Sriram Subramaniam, et al.Retrovirology|January 24, 2015
Griffithsin tandemers: flexible and potent lectin inhibitors of the human immunodeficiency virusTinoush Moulaei, Kabamba B Alexandre, Shilpa R Shenoy, et al.Biorxiv : the Preprint Server for Biology|January 3, 2024
Spatial and Temporal Coordination of Force-generating Actin-based Modules Drives Membrane Remodeling In VivoMarco Heydecker, Akiko Shitara, Desu Chen, et al.Nature Reviews. Methods Primers|July 6, 2023
Volume electron microscopyChristopher J Peddie, Christel Genoud, Anna Kreshuk, et al.Plos Biology|April 29, 2021
Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodiesXing Zhu, Dhiraj Mannar, Shanti S Srivastava, et al.The Oncologist|August 25, 2017
FDA Approval Summary: Pembrolizumab for Treatment of Metastatic Non-Small Cell Lung Cancer: First-Line Therapy and BeyondLee Pai-Scherf, Gideon M Blumenthal, Hongshan Li, et al.Nature Communications|February 9, 2022
Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variantsJames W Saville, Dhiraj Mannar, Xing Zhu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2017
FDA Approval Summary: Pembrolizumab for the Treatment of Patients with Unresectable or Metastatic MelanomaAmy Barone, Maitreyee Hazarika, Marc R Theoret, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2022
FDA Approval Summary: Decitabine and Cedazuridine Tablets for Myelodysplastic SyndromesNina Kim, Kelly J Norsworthy, Sriram Subramaniam, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2019
FDA Approval Summary: Glasdegib for Newly Diagnosed Acute Myeloid LeukemiaKelly J Norsworthy, Kunthel By, Sriram Subramaniam, et al.Pageof 23